I also want to receive my investment back. Being realistic however, CASI indicate it is not profitable enough to progress currently. Acrotech may show them the way to profitability if their trials are successful but the timelines for our payments are not encouraging.
I give it about 20% chance at receiving anything back unfortunately.
here is a clinical trial that will give results in may 2021. I will check in then to see if there is any positive outlook.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.